MIGUEL ANGEL
SANZ ALONSO
CATEDRÁTICO/A DE UNIVERSIDAD
University Hospital of Lausanne
Lausana, SuizaPublicaciones en colaboración con investigadores/as de University Hospital of Lausanne (7)
2017
-
Long-term survival of patients with CLL after allogeneic transplantation: A report from the European Society for Blood and Marrow Transplantation
Bone Marrow Transplantation, Vol. 52, Núm. 3, pp. 372-380
2015
-
Arsenic trioxide-based therapy of relapsed acute promyelocytic leukemia: registry results from the European LeukemiaNet
Leukemia, Vol. 29, Núm. 5, pp. 1084-1091
2011
-
Impact of adjunct cytogenetic abnormalities for prognostic stratification in patients with myelodysplastic syndrome and deletion 5q
Leukemia, Vol. 25, Núm. 1, pp. 110-120
2003
2001
-
Association between antifungal prophylaxis and rate of documented bacteremia in febrile neutropenic cancer patients
Clinical Infectious Diseases, Vol. 32, Núm. 11, pp. 1532-1537
1996
-
Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer
Antimicrobial Agents and Chemotherapy, Vol. 40, Núm. 5, pp. 1108-1115
1995
-
Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer
Antimicrobial Agents and Chemotherapy, Vol. 39, Núm. 2, pp. 445-452